{"id":12993,"date":"2022-10-10T12:24:23","date_gmt":"2022-10-10T10:24:23","guid":{"rendered":"https:\/\/www.endoscopy-campus.com\/?post_type=ec-news&#038;p=12993"},"modified":"2022-10-10T12:24:24","modified_gmt":"2022-10-10T10:24:24","slug":"dutch-describe-impact-of-their-national-biennial-fecal-immunochemical-test-screening-program","status":"publish","type":"ec-news","link":"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/dutch-describe-impact-of-their-national-biennial-fecal-immunochemical-test-screening-program\/","title":{"rendered":"Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In 2014, the Netherlands instituted a national program of every-other-year fecal immunochemical test (FIT) screening for colorectal cancer (CRC). Since the start of screening, within the screening age population of 55 to 75 years, 78.6% of CRC was clinically detected and 18.9% screen-detected, with 2.5% having an unknown method of detection.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After a sharp rise in CRC incidence due to screen-detected cancers, especially stage I lesions, the incidence of stages I to III CRC dropped, with stage II and IV incidence falling below the lowest prescreening incidence in 2018 and 2017, respectively.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As expected, survival in screen-detected tumors was better than clinically detected lesions. For stages III and IV CRC, screen-detected tumors were generally found earlier and were more treatable than clinically detected tumors. For example, stage III screen-detected tumors were more likely to have a T0-2 stage (36.2% vs 19.4%) as were screen-detected stage IV tumors (14.7% vs 10.4%). Further, screen-detected stage IV tumors were more likely to be N0 and have metastases in only a single organ. Screen-detected stage III and IV tumors were more likely to receive resection of the primary tumor, and stage IV screen-detected tumors were 14% more likely to undergo local therapy of metastases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In 2014, the Netherlands instituted a national program of every-other-year fecal immunochemical test (FIT) screening for colorectal cancer (CRC). Since the start of screening, within the screening age population of 55 to 75 years, 78.6% of CRC was clinically detected and 18.9% screen-detected, with 2.5% having an unknown method of detection.&nbsp; After a sharp rise &#8230; <a title=\"Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program\" class=\"read-more\" href=\"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/dutch-describe-impact-of-their-national-biennial-fecal-immunochemical-test-screening-program\/\" aria-label=\"Read more about Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program\">Read more<\/a><\/p>\n","protected":false},"template":"","categories":[1768,1769],"tags":[2058,1823,1343,1826,1898,3444],"class_list":["post-12993","ec-news","type-ec-news","status-publish","hentry","category-asge-journal-scan","category-asge-kolon","tag-colon-2","tag-colorectal-cancer","tag-crc","tag-fecal-immunochemical-test","tag-fit","tag-netherland"],"_links":{"self":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news\/12993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news"}],"about":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/types\/ec-news"}],"wp:attachment":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/media?parent=12993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/categories?post=12993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/tags?post=12993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}